Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data analysis finds.
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study

The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data analysis finds.

The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data analysis finds.

blood clot
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
US Health Authorities Ask for Pause in J&J COVID-19 Vaccination
Kerry Grens | Apr 13, 2021
The FDA and CDC are investigating a handful of reports of blood clots that occurred several days after people received the one-and-done shot.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
The Brain on COVID-19
The Brain on COVID-19
The Scientist Creative Services Team | Dec 21, 2020
Connecting the dots between COVID-19 and neurological disorders
Autopsies Indicate Blood Clots Are Lethal in COVID-19
Autopsies Indicate Blood Clots Are Lethal in COVID-19
Ashley Yeager | Jul 10, 2020
A pathologist describes his observations from examining the bodies of those who succumbed to the coronavirus.
Could Statins Reduce the Severity of COVID-19?
Could Statins Reduce the Severity of COVID-19?
Ashley Yeager | Jun 12, 2020
The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.
Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19
Alakananda Dasgupta | May 28, 2020
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
Dog Study Revives Concerns About Virus Used for Gene Therapy
Dog Study Revives Concerns About Virus Used for Gene Therapy
Jef Akst | Jan 6, 2020
Canines treated with an adeno-associated viral (AAV) vector showed evidence that the therapeutic DNA held within the virus can integrate into the host genome, risking the activation of oncogenes.
Image of the Day: Leprosy Lesion
Image of the Day: Leprosy Lesion
The Scientist Staff, The Scientist Staff | Mar 23, 2018
Researchers identify two blood-clotting proteins that could be biomarkers for cardiovascular reactions in patients with leprosy.
Image of the Day: Un-break My Heart
Image of the Day: Un-break My Heart
The Scientist Staff | Aug 8, 2017
A failing heart is easily distinguished from a healthy one by numerous tell-tale signs, including its slender, stretched-out walls, increased size, and pooled blood clots.